Published in Scand J Gastroenterol on April 01, 2004
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol (2012) 1.73
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis (2015) 1.06
Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med (2012) 1.03
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther (2014) 0.92
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci (2009) 0.89
The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol (2009) 0.89
Hematopoietic cell transplantation for Crohn's disease; is it time? World J Gastroenterol (2006) 0.87
Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol (2012) 0.86
Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterol Res Pract (2011) 0.85
Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis (2015) 0.83
High-utilizing Crohn's disease patients under psychosomatic therapy. Biopsychosoc Med (2008) 0.82
Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease. J Gen Intern Med (2009) 0.82
Estimation of quality of life in Cypriot patients with inflammatory bowel disease. World J Gastroenterol (2017) 0.78
Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol (2011) 0.78
Factor structures of the Swedish Version of the RFIPC: Investigating the Validity of Measurements of IBD Patients' Worries and Concerns. Gastroenterology Res (2010) 0.77
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomedicine (2007) 0.77
Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis. PLoS One (2015) 0.77
Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine. Qual Life Res (2014) 0.76
Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice. Int J Mol Med (2014) 0.76
Stress as a Trigger for Relapses in IBD: A Case-Crossover Study. Gastroenterology Res (2013) 0.75
Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis. PLoS One (2017) 0.75
Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol (2017) 0.75
Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterol Res Pract (2016) 0.75
Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci (2017) 0.75
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol (1992) 3.09
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther (2013) 2.90
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol (1999) 2.89
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol (2007) 2.34
Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol (2009) 2.12
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature (1985) 1.98
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol (1994) 1.66
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol (2007) 1.62
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol (1998) 1.57
Effects of an intensive weight loss program on knee joint loading in obese adults with knee osteoarthritis. Osteoarthritis Cartilage (2011) 1.51
Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis (2006) 1.50
Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol (1982) 1.47
[Integration of preventive medicine in an emergency department. A pedagogic model for improvement of communication]. Tidsskr Nor Laegeforen (1997) 1.43
Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer (1995) 1.43
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
[Combined pancreas/kidney transplantation as standard procedure in therapy of type I diabetic patients in renal failure]. Chirurg (1996) 1.38
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol (2004) 1.34
Yeast respond to hypotonic shock with a calcium pulse. J Biol Chem (1996) 1.32
Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist. Scand J Gastroenterol (1980) 1.32
Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med (2004) 1.29
HHV8 and skin cancers in immunosuppressed patients. Lancet (1996) 1.29
Physical activity and gestational weight gain: a meta-analysis of intervention trials. BJOG (2010) 1.29
Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet (1989) 1.26
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes. Endoscopy (1994) 1.21
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol (2004) 1.20
Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut (2005) 1.17
Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion (1995) 1.16
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut (1997) 1.16
Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol (2001) 1.15
Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol (2000) 1.15
The Norwegian guidelines for surveillance after polypectomy: 10-year intervals. Scand J Gastroenterol (1996) 1.15
Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine. Scand J Gastroenterol (1980) 1.15
Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol (1986) 1.15
Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol (1993) 1.13
The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) (2001) 1.11
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol (1996) 1.11
Prophylactic effect of dietary fibre in duodenal ulcer disease. Lancet (1982) 1.10
Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol (1999) 1.10
Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum (1998) 1.09
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09
Maintenance treatment of duodenal ulcer patients with a single bedtime dose of cimetidine. Scand J Gastroenterol (1979) 1.09
Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol (1996) 1.09
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07
Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol (2001) 1.07
T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer (1995) 1.07
Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol (1986) 1.06
Effect of whole body vibration exercise on muscle strength and proprioception in females with knee osteoarthritis. Knee (2009) 1.03
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol (1997) 1.03
The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol (1985) 1.03
Studies on the in vitro synthesis of beta-galactosidase: necessary components in the ribosomal wash. Arch Biochem Biophys (1974) 1.03
Role of alimentation in irritable bowel syndrome. Digestion (2003) 1.02
Increased skewing of X chromosome inactivation with age in both blood and buccal cells. Cytogenet Genome Res (2007) 1.02
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
In vivo activation of CD4+ cells in AIDS. Science (1987) 1.02
Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study. Scand J Gastroenterol (1996) 1.02
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Digestion (2007) 1.01
Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol (2004) 1.00
Ultrasound colour Doppler measurements in a single joint as measure of disease activity in patients with rheumatoid arthritis--assessment of concurrent validity. Rheumatology (Oxford) (2009) 1.00